Duncan Williams Asset Management LLC Cuts Stock Position in Global Medical REIT Inc. (NYSE:GMRE)

Duncan Williams Asset Management LLC trimmed its position in Global Medical REIT Inc. (NYSE:GMRE) by 6.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 50,958 shares of the company’s stock after selling 3,352 shares during the period. Duncan Williams Asset Management LLC’s holdings in Global Medical REIT were worth $393,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of GMRE. Janney Montgomery Scott LLC boosted its holdings in shares of Global Medical REIT by 11.3% in the fourth quarter. Janney Montgomery Scott LLC now owns 143,447 shares of the company’s stock valued at $1,107,000 after acquiring an additional 14,532 shares in the last quarter. SG Americas Securities LLC lifted its position in Global Medical REIT by 13.8% in the fourth quarter. SG Americas Securities LLC now owns 25,828 shares of the company’s stock valued at $199,000 after purchasing an additional 3,128 shares during the period. JPMorgan Chase & Co. boosted its holdings in Global Medical REIT by 54.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 231,927 shares of the company’s stock valued at $2,298,000 after purchasing an additional 81,596 shares in the last quarter. Franklin Resources Inc. increased its position in Global Medical REIT by 228.9% during the 3rd quarter. Franklin Resources Inc. now owns 114,988 shares of the company’s stock worth $1,073,000 after purchasing an additional 80,030 shares during the period. Finally, Barclays PLC raised its stake in shares of Global Medical REIT by 87.1% during the 3rd quarter. Barclays PLC now owns 154,051 shares of the company’s stock worth $1,527,000 after buying an additional 71,704 shares in the last quarter. 57.52% of the stock is owned by institutional investors and hedge funds.

Global Medical REIT Stock Down 0.1 %

GMRE stock opened at $7.94 on Friday. The company has a current ratio of 0.28, a quick ratio of 0.28 and a debt-to-equity ratio of 1.26. The company’s 50-day moving average price is $8.18 and its 200 day moving average price is $8.97. Global Medical REIT Inc. has a 52 week low of $7.33 and a 52 week high of $10.46. The company has a market cap of $530.08 million, a P/E ratio of -396.55, a P/E/G ratio of 1.34 and a beta of 1.23.

Global Medical REIT (NYSE:GMRE) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.21 by ($0.18). Global Medical REIT had a return on equity of 0.86% and a net margin of 3.23%. The firm had revenue of $34.26 million for the quarter, compared to analysts’ expectations of $34.88 million. During the same period last year, the firm earned $0.23 EPS. On average, research analysts expect that Global Medical REIT Inc. will post 0.81 earnings per share for the current fiscal year.

Global Medical REIT Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, January 8th. Shareholders of record on Friday, December 20th were issued a $0.21 dividend. This represents a $0.84 annualized dividend and a yield of 10.59%. The ex-dividend date of this dividend was Friday, December 20th. Global Medical REIT’s dividend payout ratio (DPR) is -4,200.00%.

Analyst Upgrades and Downgrades

Separately, Berenberg Bank assumed coverage on Global Medical REIT in a research note on Friday, October 18th. They issued a “buy” rating and a $11.75 price target on the stock.

About Global Medical REIT

Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.